Q Zheng, X Xia, X Zou, Y Dong, S Wang, Y Xue, L Shen, Z Wang, A Wang, ... Proceedings of the 29th ACM SIGKDD Conference on Knowledge Discovery and …, 2023. 414: 2023: Resource aware person re-identification across multiple resolutions. Y Wang, L Wang, Y You, X Zou, V Chen, S Li, G Huang, B Hariharan, ...

Jan 6, 2021 · In the present study, we engineered mammalian extracellular vesicles (EVs) to deliver a host restriction factor, interferon-induced transmembrane protein 3 (IFITM3), for the treatment of ZIKV infection. Our results demonstrated that the IFITM3-containing EVs (IFITM3-Exos) suppressed ZIKV viremia by a 2-log reduction in pregnant mice.

Zou X, Yuan M, Zhang T, Wei H, Xu S, Jiang N, Zheng N, Wu Z. Extracellular vesicles expressing a single-chain variable fragment of an HIV-1 specific antibody selectively target Env + tissues. Theranostics 2019; 9(19):5657-5671. doi:10.7150/thno.33925. https://www.thno.org/v09p5657.htm

Xue ZOU | Cited by 169 | of Nanjing University, Nanjing (NJU) | Read 6 publications | Contact Xue ZOU

Jul 29, 2019 · Results: 10E8 scFv -exos efficiently targeted CHO cells expressing a trimeric gp140 on their surface (Env + cells) in vitro, as demonstrated by confocal imaging and flow cytometry. 10E8 scFv -exos loaded with Cur or miR-143 showed specific killing of Env + cells.

Affiliations: [School of Intelligent and Electronic Engineering, Dalian Neusoft University of Information, Dalian, China].

Xue ZOU of Duke University, North Carolina (DU) | Contact Xue ZOU